NCT06668974Completed
Causal Associations Between Allergic Rhinitis and Asthma
Bidirectional Mendelian Randomization Study Reveals Causal Associations Between Allergic Rhinitis and Asthma
Source: ClinicalTrials.gov · Last updated 1 Nov 2024
Brief summary (registry, in English)
This study investigates the causal relationship between allergic rhinitis and asthma using a bidirectional two-sample Mendelian randomization approach. Genetic data were derived from UK Biobank for allergic rhinitis and from Finnish biobank for asthma. This analysis aims to clarify the potential causal link between these two conditions.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 239607 (actual)
- First submitted
- 30 Oct 2024
- Start date
- 1 Oct 2024
- Primary completion date
- 15 Oct 2024
- Lead sponsor
- Zhibin Xu
- Diseases
- Asthma
- NCT number
- NCT06668974
What you commit to
- Study type: Observational
- Participants enrolled: 239607
- From 1 Oct 2024 to the primary completion date, 15 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Individuals without genetic data.
- Participants with incomplete phenotype or genotype data.
Who the study is looking for
- Individuals diagnosed with allergic rhinitis or asthma.
- Availability of genetic data in the UK Biobank or Finnish biobank.
Age in the registry: 0 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical University Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.